Healing support for broken pelvic and leg bones
Part of Injuries & trauma clinical trials.
This study tests a daily injection that may help heal broken pelvic or leg bones faster in people with certain health conditions like diabetes or smoking. It is for adults 50 and older who have had a low-energy fracture.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older.
- You have a broken pelvic bone or a broken leg bone (not the hip) from a simple fall.
- You have at least one of these: diabetes, kidney problems, use of steroid medicine, current or past smoking, nerve damage, or poor blood flow in your legs.
- You or someone who helps you can give a daily injection.
- You have not used certain bone or heart medicines in the last 6 months.
- You do not have severe kidney disease, high calcium levels, or a history of bone cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests teriparatide (a hormone-like bone medicine) to improve bone health in people with advanced chronic kidney disease who are at risk for weak, low-turnover bone. It may help by changing how quickly your bones break down and rebuild.
This trial tests a daily injection called abaloparatide, which helps strengthen bones and reduce the chance of breaking a bone. It is for postmenopausal women with osteoporosis who are at higher risk of fractures.
This trial tests teriparatide, a medication that helps build bone, to see if it can speed recovery and help certain enlisted Army members return to training duty after a tibia bone injury. You may be asked to self-administer the medication while you recover and take part in study follow-ups.
This study looks at ways to prevent and treat “brittle bone” refractures after a recent fracture in people with osteoporosis. If you’ve had a new hip, spine, or other bone fracture, the trial may test strategies to lower the chance of another fracture.
This study tests whether giving teriparatide (a daily injection that helps build bone) at different times of day makes it work better for women with postmenopausal osteoporosis and very low bone density. If you qualify, you might get the medicine either in the morning or evening, and researchers will track how your bone density changes.
This study tests a new version of a medicine called abaloparatide (used for bone health) to see if it works the same as the approved version (Tymlos). It is for healthy adults aged 40–65 who are willing to stay at the clinic for a few days and have blood tests.
Hear when a new Lower Extremity Fractures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.